Central regions | Finance, business | Technology & innovation

Russians develop advanced multiple myeloma drug candidate

16 Feb '18
Hemopharm, a Russian biotech company, is developing a drug candidate that might help multiple myeloma patients.

Multiple myeloma is a cancer of plasma cells. Initially, often no symptoms are noticed; but when advanced, bone pain, bleeding, frequent infections, and anemia may occur. Complications may include amyloidosis. Believed to be incurable, the disease stays with the patient for as long as he lives, and all physicians can do is increase his life expectancy and improve the quality of life. Drugs currently available in the market are known for high toxicity and low efficacy, which necessitates the development of low-toxicity target drugs to boost the patient’s resistance.

The new Hemopharm solution is expected to evolve to be such a drug. No direct competition has been reported so far in the global pharmaceutical market. The drug candidate is a humanized antibody with purportedly outstanding anti-tumor activity and low toxicity with proven in vivo efficacy.

Last fall Primer Capital, a Russian VC fund that invests primarily in pharmaceutical and biotech projects, supported an early development stage financially. Primer Capital Executive Director Elizaveta Rozhdestvenskaya then said in an interview that the fund “expected preclinical trials to provide ample evidence to the high efficacy of the drug” and promised to “readily consider participating in the project’s next funding round to back the clinical trial stage.”
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
COMMENT ON THIS STORY
Find Related Content

Locations:

Tags: investment (550) / Primer Capital (5) / multiple myeloma (0) / Hemopharm (0) /

Latest News: Central regions
14 Aug '18 | Transport, logistics | Finance, business
13 Aug '18 | Finance, business | Technology & innovation
8 Aug '18 | Energy, utilities | Technology & innovation
 

Feature stories

7 Jun '18
Russian scientists have come up with a new method of...
3 Apr '18
In regions most of European Russians will hardly ever...
21 Nov '17
Russian scientists have come up with what they say is...
Search (News archive - 21265)
Advertising
RB_Partners_Report
Advertising
gcvsymposium
Advertising
Independent Software Developers Forum
Advertising
Marchmont News

Latest News

14 Aug '18
Russia’s Internet Initiatives Development Fund is...
13 Aug '18
VEB Innovations, a subsidiary of Russia’s VEB Bank,...
8 Aug '18
A Skolkovo team has come up with a proprietary...

Most read stories from last week

13 Aug '18
VEB Innovations, a subsidiary of Russia’s VEB Bank,...
14 Aug '18
Russia’s Internet Initiatives Development Fund is...